Search hospitals > Georgia > Atlanta
Emory University
Claim this profileAtlanta, Georgia 30322
Global Leader in Heart Failure
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Cancer
Conducts research for Lymphoma
Conducts research for Leukemia
1257 reported clinical trials
153 medical researchers
Summary
Emory University is a medical facility located in Atlanta, Georgia. This center is recognized for care of Heart Failure, Human Immunodeficiency Virus Infection, Cancer, Lymphoma, Leukemia and other specialties. Emory University is involved with conducting 1,257 clinical trials across 1,255 conditions. There are 153 research doctors associated with this hospital, such as Edmund Waller, MD, Olatunji Alese, William G. Blum, and Conor Steuer.Area of expertise
1Heart Failure
Global LeaderStage IV
2Human Immunodeficiency Virus Infection
Global LeaderHIV RNA
HIV
ART
Top PIs
Edmund Waller, MDEmory University Hospital1 year of reported clinical research
Studies Acute Myeloid Leukemia
Studies Leukemia
15 reported clinical trials
22 drugs studied
Olatunji AleseEmory University Hospital/Winship Cancer Institute1 year of reported clinical research
Studies Tumors
Studies Solid Tumors
14 reported clinical trials
38 drugs studied
William G. BlumWinship Cancer Institute of Emory University3 years of reported clinical research
Studies Leukemia
Studies Acute Myeloid Leukemia
13 reported clinical trials
38 drugs studied
Conor SteuerEmory University Hospital/Winship Cancer Institute1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
33 drugs studied
Clinical Trials running at Emory University
Multiple Myeloma
Polycystic Kidney Disease
Kidney Disease
Breast Cancer
Heart Failure
Plasma Cell Neoplasms
Depression
Bladder Cancer
Chronic Kidney Disease
Embolism
DVRd + Ciltacabtagene Autoleucel / ASCT
for Multiple Myeloma
This trial is testing a combination of four drugs followed by either a special cell therapy or a stem cell transplant in newly diagnosed multiple myeloma patients who can have a transplant. The drugs fight cancer and boost immunity, while the cell therapy reprograms immune cells to attack cancer, and the stem cell transplant rebuilds bone marrow.
Recruiting4 awards Phase 34 criteria
bb2121
for Multiple Myeloma
This study is a multi-cohort, open-label, multicenter Phase 2 study to evaluate the efficacy and safety of bb2121 in participants with relapsed and refractory multiple myeloma (RRMM) (Cohort 1), in participants with RRMM who receive bridging therapy with talquetamab (Cohort 1b), in participants with multiple myeloma (MM) having progressed within 18 months of initial treatment with autologous stem cell transplantation (ASCT) (Cohort 2a) and without ASCT (Cohort 2b) or, in participants with inadequate response post ASCT during initial treatment (Cohort 2c) and the efficacy and safety of bb2121 used in combination with lenalidomide maintenance in participants with suboptimal response post ASCT (Cohort 3). Approximately 264 participants will be enrolled into one of three cohorts. Cohort 1 (including cohort 1b) will enroll approximately 126 RRMM subjects with ≥ 3 prior anti-myeloma treatment regimens. Cohort 2a will enroll approximately 39 MM subjects, with 1 prior anti-myeloma therapy including ASCT and with early relapse. Cohort 2b will enroll approximately 39 MM subjects with 1 prior anti-myeloma therapy not including ASCT and with early relapse. Cohort 2c will enroll approximately 30 MM subjects with inadequate response to ASCT during their initial anti-myeloma therapy. The cohorts will start in parallel and independently. Cohort 3 will enroll approximately 30 newly diagnosed multiple myeloma (NDMM) participants with suboptimal response to ASCT.
Recruiting3 awards Phase 25 criteria
Long-term Follow-up
for Cilta-cel in Multiple Myeloma
The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.
Recruiting3 awards Phase 42 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Emory University?
Emory University is a medical facility located in Atlanta, Georgia. This center is recognized for care of Heart Failure, Human Immunodeficiency Virus Infection, Cancer, Lymphoma, Leukemia and other specialties. Emory University is involved with conducting 1,257 clinical trials across 1,255 conditions. There are 153 research doctors associated with this hospital, such as Edmund Waller, MD, Olatunji Alese, William G. Blum, and Conor Steuer.
Where is Emory University located?
**Directions to Emory University Hospital Midtown, Atlanta, GA:**
- From I-75/85 Northbound, continue on I-85 North to Clairmont Road, exit #91.
- Follow signs to Decatur, drive 4-5 miles on Clairmont Road to North Decatur Road, then turn right.
- Proceed one mile to Clifton Road, turn right, and the hospital is 100 yards on the left.
Who should I call to ask about financial aid or insurance network?
**Emory University Financial Assistance:**
- For staff and faculty experiencing financial hardship, contact the Emory University Hardship Fund at hardship.fund@emory.edu or fax 404-712-1470.
- For student insurance inquiries, reach out to the Emory University Student Health Insurance Plan (EUSHIP) at 404-727-7560. For other billing and insurance issues, call 404-727-8721.
**Emory Healthcare Financial Assistance:**
- Contact a Financial Counselor at (404) 778-7318 for insurance coverage review, out-of-pocket obligations, and financial coverage options.
- Access the Emory Healthcare Financial Assistance Policy, Plain Language Summary, and Application Form on their website.
What insurance does Emory University accept?
Emory University accepts most major insurance plans, including private, employer-based, Federal health insurance marketplace plans, traditional Medicare, and Medicare Advantage plans. Employees of Emory University can choose from three medical plans: the Aetna HSA Plan, the Aetna POS Plan, and the Kaiser Permanente Plan. For detailed coverage information, contact your insurance carrier directly or call Emory Healthcare's information line at 404-778-7777 or 1-800-75-EMORY (1-800-753-6679).
What awards or recognition has Emory University received?
Emory University Hospital, located in Atlanta, Georgia, secured a record $894.7 million in research funding in fiscal year 2021, with $526 million coming from the National Institutes of Health (NIH). It was also chosen as the first recipient of a $24.8 million cooperative agreement from the Advanced Research Projects Agency for Health (ARPA-H), underscoring its role in pioneering biomedical and health research.